In this month’s Transplantation, Tarek Alha
mad, MD, reports that the use of midorine to maintain blood pressure during dialysis associates with transplant complications. The study integrated three databases for the analysis, the Organ Procurement and Transplant Network, pharmaceutical claims data and Medicare billing claims databases. In an accompanying editorial, Chon and Josephson write, “Beyond its clinical utility as a predictive marker, its promise may lie in the opportunity it provides the transplant community to refine and improve the current program risk profiling model and the tool it gives the practitioner to identify who needs intensified cardiac care and encouragement for earlier transplantation.”